On the recordMarch 29, 2023
In the Grassley-Wyden 2-year investigation into insulin price-gouging, we found that that PBM scheme encourages drug makers to spike the drug list price.
Source
congress.govIn the Grassley-Wyden 2-year investigation into insulin price-gouging, we found that that PBM scheme encourages drug makers to spike the drug list price.
Grassley discusses findings from an investigation into insulin pricing.
Share & report
More from Chuck Grassley
Ahead of a high-stakes election happening amid an unprecedented global pandemic, the FBI turned its back on its national security mission.
I want to put people on the agenda that I can help the president be successful in his nominees, and that’s all I can say at this point.
More importantly, this report offers a clear path forward for the Secret Service to improve, so it can prevent another Butler from ever happening again.
My oversight has shown time and again how the FBI’s CR-15 unit was weaponized to execute one-sided political attacks, particularly against President Trump and his allies.